Biovance Signs MoU with MIET to Advance Pharmacovigilance and Research Training

Biovance Solutions, a UK based Company, leading provider of pharmacovigilance, regulatory, and pre-clinical research services, has signed a Memorandum of Understanding (MoU) with MIET (Meerut Institute of Engineering & Technology) to foster collaboration in the areas of Pharmacovigilance (PV), Regulatory Affairs, and Pre-Clinical Trial Services.

This strategic association aims to bridge the gap between industry and academia by combining Biovance Solutions’ domain expertise with MIET’s academic excellence and infrastructure. The collaboration will focus on advancing applied research, knowledge sharing, and skill development aligned with current industry and regulatory requirements.

A key pillar of the MoU is capacity building, with both institutions jointly working towards the development and delivery of affordable, high-quality training programs in pharmacovigilance, regulatory sciences, and pre-clinical research. These initiatives are designed to equip students, researchers, and early-career professionals with industry-relevant competencies and hands-on exposure.

Speaking on the occasion, representatives from both Biovance Solutions emphasized that the partnership reflects the organization’s commitment to nurturing future-ready talent and strengthening compliance-driven research ecosystems. MIET leadership echoed similar sentiments, highlighting the importance of industry collaboration in enhancing employability and research readiness among students.

Through this MoU, Biovance Solutions and MIET envision creating a sustainable platform for academic–industry collaboration that supports innovation, regulatory excellence, and workforce development in the life sciences sector.

Present on the occasion were Mr. Puneet Agarwal (Vice-Chairman, MIET Group of Institutions), Ms. Punam Kumari, Founder and Managing Director (Biovance Solutions), Dr. Alok Sharma and Ms Garima Agarwal.

Biovance Solutions is a life sciences services organization specializing in pharmacovigilance, regulatory affairs, and pre-clinical research. The company supports global healthcare and medical device organizations with compliance-driven, end-to-end solutions, combining scientific expertise, quality systems, and a strong focus on ethical research and talent development.